These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9624770)

  • 1. General practitioner perceptions of treatment benefits and costs in patients with hyperlipidaemia.
    Hobbs FD; Holmes J; Pugner K
    Br J Gen Pract; 1998 Feb; 48(427):983-4. PubMed ID: 9624770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-pharmacological therapy of hyperlipidaemia.
    Pathak UN; Gurubacharya DL
    Nepal Med Coll J; 2003 Dec; 5(2):109-12. PubMed ID: 15024782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of hyperlipidaemia.
    Stocks N; Allan J; Mansfield PR
    Aust Fam Physician; 2005 Jun; 34(6):447-53. PubMed ID: 15931403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting feasibility and acceptability of a practice-based educational intervention to support evidence-based prescribing: a qualitative study.
    Watkins C; Timm A; Gooberman-Hill R; Harvey I; Haines A; Donovan J
    Fam Pract; 2004 Dec; 21(6):661-9. PubMed ID: 15528289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for the management of hyperlipidaemia in general practice. Towards the primary prevention of coronary heart disease. Royal College of General Practitioners.
    Occas Pap R Coll Gen Pract; 1992 Mar; (55):1-15. PubMed ID: 1296829
    [No Abstract]   [Full Text] [Related]  

  • 6. Attitude changes of general practitioners towards lowering LDL cholesterol.
    Strandberg TE; Pitkänen A; Larjo P; Hirvonen P; Kohvakka A
    J Cardiovasc Risk; 1998 Feb; 5(1):43-6. PubMed ID: 9816555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary prevention of cardiovascular diseases by lipid-lowering treatment in German general practice: results from GPs ignoring guidelines and risk calculators.
    Oriol-Zerbe C; Abholz HH
    Eur J Gen Pract; 2007; 13(1):27-34. PubMed ID: 17366291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of physician's attitudes and practices toward lipid-lowering management strategies.
    Goldberg RJ; Rosen J; Roselli A; Lewis B
    Cardiology; 2007; 107(4):302-6. PubMed ID: 17264510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic benefits of aggressive lipid lowering: a managed care perspective.
    McKenney JM; Kinosian B
    Am J Manag Care; 1998 Jan; 4(1):65-74. PubMed ID: 10179907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human and economic costs of undertreatment with statins.
    Durrington P
    Int J Clin Pract; 2002 Jun; 56(5):357-68. PubMed ID: 12137445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cholesterol-lowering therapy; a recommendation from the Health Council].
    Simoons ML
    Ned Tijdschr Geneeskd; 2000 Dec; 144(51):2442-4. PubMed ID: 11151651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C; Olsson AG
    Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in diet quality for coronary heart disease prevention between 1980-1982 and 2000-2002: The Minnesota Heart Survey.
    Lee S; Harnack L; Jacobs DR; Steffen LM; Luepker RV; Arnett DK
    J Am Diet Assoc; 2007 Feb; 107(2):213-22. PubMed ID: 17258957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of quality of dietary fat on serum cholesterol and coronary heart disease: focus on plant sterols and other non-glyceride components.
    Ghafoorunissa
    Natl Med J India; 2009; 22(3):126-32. PubMed ID: 19764688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of uncontrolled hyperlipidaemia in high-risk ambulatory patients in primary care.
    Hildemann S; Karmann B; Pittrow D; Barho C; Darius H; Bode C
    Curr Med Res Opin; 2008 Jun; 24(6):1659-68. PubMed ID: 18457604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term effect of dietary advice in men with coronary disease: follow-up of the Diet and Reinfarction trial (DART).
    Ness AR; Hughes J; Elwood PC; Whitley E; Smith GD; Burr ML
    Eur J Clin Nutr; 2002 Jun; 56(6):512-8. PubMed ID: 12032650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hyperlipidemia.
    Margolis S
    Md State Med J; 1970 Nov; 19(11):101-3. PubMed ID: 5523343
    [No Abstract]   [Full Text] [Related]  

  • 19. The reality of treating dyslipidaemia in patients with coronary heart disease: a primary care survey.
    Wright DJ; Grayson AD; Jackson M; Dainty C
    Int J Clin Pract; 2003; 57(6):488-91. PubMed ID: 12918888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choosing the most appropriate therapy for lipid disorders.
    Simons LA
    Aust Fam Physician; 2000 Mar; 29(3):199-203. PubMed ID: 10785984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.